HEADER LUMINESCENT PROTEIN 04-OCT-04 1XMZ TITLE CRYSTAL STRUCTURE OF THE DARK STATE OF KINDLING FLUORESCENT PROTEIN TITLE 2 KFP FROM ANEMONIA SULCATA COMPND MOL_ID: 1; COMPND 2 MOLECULE: GFP-LIKE NON-FLUORESCENT CHROMOPROTEIN FP595 CHAIN 1; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: GFP-LIKE NON-FLUORESCENT CHROMOPROTEIN FP595 CHAIN 2; COMPND 7 CHAIN: C, D; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ANEMONIA SULCATA; SOURCE 3 ORGANISM_COMMON: SNAKE-LOCKS SEA ANEMONE; SOURCE 4 ORGANISM_TAXID: 6108; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: JM-109; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PQE-30; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: ANEMONIA SULCATA; SOURCE 13 ORGANISM_COMMON: SNAKE-LOCKS SEA ANEMONE; SOURCE 14 ORGANISM_TAXID: 6108; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 17 EXPRESSION_SYSTEM_STRAIN: JM-109; SOURCE 18 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 19 EXPRESSION_SYSTEM_VECTOR: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PQE-30 KEYWDS FLUORESCENT PROTEIN, CHROMOPHORE STRUCTURE, ASCP595, LUMINESCENT KEYWDS 2 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR M.L.QUILLIN,D.M.ANSTROM,X.SHU,S.O'LEARY,K.KALLIO,D.M.CHUDAKOV, AUTHOR 2 S.J.REMINGTON REVDAT 8 28-FEB-24 1XMZ 1 COMPND SOURCE REMARK DBREF REVDAT 8 2 1 SEQADV SEQRES HELIX SHEET REVDAT 8 3 1 LINK SITE ATOM REVDAT 7 23-AUG-23 1XMZ 1 REMARK REVDAT 6 20-OCT-21 1XMZ 1 REMARK SEQADV LINK REVDAT 5 13-JUL-11 1XMZ 1 VERSN REVDAT 4 30-JUN-09 1XMZ 1 SEQADV REVDAT 3 24-FEB-09 1XMZ 1 VERSN REVDAT 2 15-AUG-06 1XMZ 1 AUTHOR JRNL REVDAT 1 19-APR-05 1XMZ 0 JRNL AUTH M.L.QUILLIN,D.M.ANSTROM,X.SHU,S.O'LEARY,K.KALLIO, JRNL AUTH 2 D.M.CHUDAKOV,S.J.REMINGTON JRNL TITL KINDLING FLUORESCENT PROTEIN FROM ANEMONIA SULCATA: JRNL TITL 2 DARK-STATE STRUCTURE AT 1.38 RESOLUTION JRNL REF BIOCHEMISTRY V. 44 5774 2005 JRNL REFN ISSN 0006-2960 JRNL PMID 15823036 JRNL DOI 10.1021/BI047644U REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH K.A.LUKYANOV,A.F.FRADKOV,N.G.GURSKAYA,M.V.MATZ,Y.A.LABAS, REMARK 1 AUTH 2 A.P.SAVITSKY,M.L.MARKELOV,A.G.ZARAISKY,X.ZHAO,Y.FANG,W.TAN, REMARK 1 AUTH 3 S.A.LUKYANOV REMARK 1 TITL NATURAL ANIMAL COLORATION CAN BE DETERMINED BY A REMARK 1 TITL 2 NONFLUORESCENT GREEN FLUORESCENT PROTEIN HOMOLOG REMARK 1 REF J.BIOL.CHEM. V. 275 25879 2000 REMARK 1 REFN ISSN 0021-9258 REMARK 1 REFERENCE 2 REMARK 1 AUTH V.I.MARTYNOV,A.P.SAVITSKY,N.Y.MARTYNOVA,P.A.SAVITSKY, REMARK 1 AUTH 2 K.A.LUKYANOV,S.A.LUKYANOV REMARK 1 TITL ALTERNATIVE CYCLIZATION IN GFP-LIKE PROTEINS FAMILY. THE REMARK 1 TITL 2 FORMATION AND STRUCTURE OF THE CHROMOPHORE OF A PURPLE REMARK 1 TITL 3 CHROMOPROTEIN FROM ANEMONIA SULCATA REMARK 1 REF J.BIOL.CHEM. V. 276 21012 2001 REMARK 1 REFN ISSN 0021-9258 REMARK 1 REFERENCE 3 REMARK 1 AUTH M.E.BULINA,D.M.CHUDAKOV,N.N.MUDRIK,K.A.LUKYANOV REMARK 1 TITL INTERCONVERSION OF ANTHOZOA GFP-LIKE FLUORESCENT AND REMARK 1 TITL 2 NONFLUORESCENT PROTEINS BY MUTAGENESIS REMARK 1 REF BMC BIOCHEM. V. 3 2002 REMARK 1 REFN ESSN 1471-2091 REMARK 1 REFERENCE 4 REMARK 1 AUTH D.M.CHUDAKOV,A.V.FOEFANOV,N.N.MUDRIK,S.LUKYANOV,K.A.LUKYANOV REMARK 1 TITL CHROMOPHORE ENVIRONMENT PROVIDES CLUE TO "KINDLING REMARK 1 TITL 2 FLUORESCENT PROTEIN" RIDDLE REMARK 1 REF J.BIOL.CHEM. V. 278 7215 2002 REMARK 1 REFN ISSN 0021-9258 REMARK 1 REFERENCE 5 REMARK 1 AUTH D.M.CHUDAKOV,V.V.BELOUSOV,A.G.ZARAISKY,V.V.NOVOSELOV, REMARK 1 AUTH 2 D.B.STAROVEROV,D.B.ZOROV,S.LUKYANOV,K.A.LUKYANOV REMARK 1 TITL KINDLING FLUORESCENT PROTEINS FOR PRECISE IN VIVO REMARK 1 TITL 2 PHOTOLABELING REMARK 1 REF NAT.BIOTECHNOL. V. 21 191 2003 REMARK 1 REFN ISSN 1087-0156 REMARK 1 REFERENCE 6 REMARK 1 AUTH I.V.YAMPOLSKY,S.J.REMINGTON,V.K.POTAPOV,K.A.LUKYANOV REMARK 1 TITL SYNTHESIS AND PROPERTIES OF THE CHROMOPHORE OF ASULCP REMARK 1 TITL 2 CHROMOPROTEIN FROM ANEMONIA SULCATA REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 2 REMARK 2 RESOLUTION. 1.38 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.38 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : SHELLS REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.140 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.139 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.191 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 4307 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 89373 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.136 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.135 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.183 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 3969 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 81937 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3617 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 463 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 4108.0 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 3322.0 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 46 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 38699 REMARK 3 NUMBER OF RESTRAINTS : 48588 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 ANGLE DISTANCES (A) : 0.031 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.033 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.070 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.076 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.024 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.004 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.035 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.090 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: A SOLVENT MODEL BASED ON MOEWS & KRETSINGER, 1975 REMARK 3 WAS APPLIED DURING REFINEMENT. REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1XMZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-OCT-04. REMARK 100 THE DEPOSITION ID IS D_1000030533. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-NOV-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 14-BM-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 89428 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.380 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 200 DATA REDUNDANCY : 7.300 REMARK 200 R MERGE (I) : 0.04400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 49.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.38 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.43 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.16600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 8.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: PDB ENTRY 1G7K REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.05 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 26% PEG 1550, 0.14 M SODIUM CITRATE, REMARK 280 0.1 M TRIS, PH 9.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 46.37500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 46.37500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 38.26000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 62.70000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 38.26000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 62.70000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 46.37500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 38.26000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 62.70000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 46.37500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 38.26000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 62.70000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: OCTAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: OCTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 34420 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 31410 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -195.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 76.52000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 139.12500 REMARK 400 REMARK 400 COMPOUND REMARK 400 THE AMINO GROUP (NH2 240) FOLLOWING CYS 62 IS DERIVED FROM REMARK 400 THE PEPTIDE NITROGEN OF MET 63 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -10 REMARK 465 ARG A -9 REMARK 465 GLY A -8 REMARK 465 SER A -7 REMARK 465 HIS A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 HIS A -1 REMARK 465 GLY A 0 REMARK 465 SER A 1 REMARK 465 ALA A 2 REMARK 465 SER A 3 REMARK 465 GLU C 206 REMARK 465 LYS C 207 REMARK 465 MET B -10 REMARK 465 ARG B -9 REMARK 465 GLY B -8 REMARK 465 SER B -7 REMARK 465 HIS B -6 REMARK 465 HIS B -5 REMARK 465 HIS B -4 REMARK 465 GLU D 206 REMARK 465 LYS D 207 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP C 129 CB - CG - OD1 ANGL. DEV. = 5.4 DEGREES REMARK 500 ASP C 151 C - N - CA ANGL. DEV. = 18.1 DEGREES REMARK 500 GLY C 152 C - N - CA ANGL. DEV. = 12.8 DEGREES REMARK 500 ARG C 155 CD - NE - CZ ANGL. DEV. = 11.0 DEGREES REMARK 500 ARG C 155 NE - CZ - NH1 ANGL. DEV. = 4.5 DEGREES REMARK 500 ARG C 155 NE - CZ - NH1 ANGL. DEV. = -3.5 DEGREES REMARK 500 ARG C 155 NE - CZ - NH2 ANGL. DEV. = 3.4 DEGREES REMARK 500 TYR C 211 CB - CG - CD1 ANGL. DEV. = 3.7 DEGREES REMARK 500 TYR C 214 CB - CG - CD2 ANGL. DEV. = 4.8 DEGREES REMARK 500 TYR C 214 CB - CG - CD1 ANGL. DEV. = -4.1 DEGREES REMARK 500 ASP C 223 CB - CG - OD2 ANGL. DEV. = 7.3 DEGREES REMARK 500 HIS B -2 C - N - CA ANGL. DEV. = 39.5 DEGREES REMARK 500 ASP D 151 CA - CB - CG ANGL. DEV. = 13.4 DEGREES REMARK 500 ARG D 155 NE - CZ - NH1 ANGL. DEV. = -4.5 DEGREES REMARK 500 TYR D 211 CB - CG - CD2 ANGL. DEV. = 4.3 DEGREES REMARK 500 TYR D 211 CB - CG - CD1 ANGL. DEV. = -3.8 DEGREES REMARK 500 TYR D 211 CB - CG - CD1 ANGL. DEV. = 4.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP C 151 -31.61 70.26 REMARK 500 LYS C 209 -22.85 -144.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 HIS B -3 HIS B -2 -73.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NH2 A 63 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BME C 250 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BME C 251 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BME C 252 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BME C 253 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NH2 B 63 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BME D 250 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BME D 251 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BME D 252 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1EMA RELATED DB: PDB REMARK 900 GFP REMARK 900 RELATED ID: 1G7K RELATED DB: PDB REMARK 900 DSRED REMARK 900 RELATED ID: 1UIS RELATED DB: PDB REMARK 900 EQFP611 REMARK 900 RELATED ID: 1MOU RELATED DB: PDB REMARK 900 RTMS5 REMARK 999 REMARK 999 SEQUENCE REMARK 999 RESIDUE MET 63, TYR 64 AND GLY 65 ARE MODIFIED TO REMARK 999 FORM A CHROMOPHORE (CRK 65) IN BOTH CHAINS DBREF 1XMZ A 2 62 UNP Q9GZ28 NFCP_ANESU 2 62 DBREF 1XMZ C 65 232 UNP Q9GZ28 NFCP_ANESU 63 232 DBREF 1XMZ B 2 62 UNP Q9GZ28 NFCP_ANESU 2 62 DBREF 1XMZ D 65 232 UNP Q9GZ28 NFCP_ANESU 63 232 SEQADV 1XMZ MET A -10 UNP Q9GZ28 INITIATING METHIONINE SEQADV 1XMZ ARG A -9 UNP Q9GZ28 EXPRESSION TAG SEQADV 1XMZ GLY A -8 UNP Q9GZ28 EXPRESSION TAG SEQADV 1XMZ SER A -7 UNP Q9GZ28 EXPRESSION TAG SEQADV 1XMZ HIS A -6 UNP Q9GZ28 EXPRESSION TAG SEQADV 1XMZ HIS A -5 UNP Q9GZ28 EXPRESSION TAG SEQADV 1XMZ HIS A -4 UNP Q9GZ28 EXPRESSION TAG SEQADV 1XMZ HIS A -3 UNP Q9GZ28 EXPRESSION TAG SEQADV 1XMZ HIS A -2 UNP Q9GZ28 EXPRESSION TAG SEQADV 1XMZ HIS A -1 UNP Q9GZ28 EXPRESSION TAG SEQADV 1XMZ GLY A 0 UNP Q9GZ28 EXPRESSION TAG SEQADV 1XMZ SER A 1 UNP Q9GZ28 EXPRESSION TAG SEQADV 1XMZ NH2 A 63 UNP Q9GZ28 CLONING ARTIFACT SEQADV 1XMZ CRK C 65 UNP Q9GZ28 MET 63 CHROMOPHORE SEQADV 1XMZ CRK C 65 UNP Q9GZ28 TYR 64 CHROMOPHORE SEQADV 1XMZ CRK C 65 UNP Q9GZ28 GLY 65 CHROMOPHORE SEQADV 1XMZ GLY C 143 UNP Q9GZ28 ALA 143 ENGINEERED MUTATION SEQADV 1XMZ MET B -10 UNP Q9GZ28 INITIATING METHIONINE SEQADV 1XMZ ARG B -9 UNP Q9GZ28 EXPRESSION TAG SEQADV 1XMZ GLY B -8 UNP Q9GZ28 EXPRESSION TAG SEQADV 1XMZ SER B -7 UNP Q9GZ28 EXPRESSION TAG SEQADV 1XMZ HIS B -6 UNP Q9GZ28 EXPRESSION TAG SEQADV 1XMZ HIS B -5 UNP Q9GZ28 EXPRESSION TAG SEQADV 1XMZ HIS B -4 UNP Q9GZ28 EXPRESSION TAG SEQADV 1XMZ HIS B -3 UNP Q9GZ28 EXPRESSION TAG SEQADV 1XMZ HIS B -2 UNP Q9GZ28 EXPRESSION TAG SEQADV 1XMZ HIS B -1 UNP Q9GZ28 EXPRESSION TAG SEQADV 1XMZ GLY B 0 UNP Q9GZ28 EXPRESSION TAG SEQADV 1XMZ SER B 1 UNP Q9GZ28 EXPRESSION TAG SEQADV 1XMZ NH2 B 63 UNP Q9GZ28 CLONING ARTIFACT SEQADV 1XMZ CRK D 65 UNP Q9GZ28 MET 63 CHROMOPHORE SEQADV 1XMZ CRK D 65 UNP Q9GZ28 TYR 64 CHROMOPHORE SEQADV 1XMZ CRK D 65 UNP Q9GZ28 GLY 65 CHROMOPHORE SEQADV 1XMZ GLY D 143 UNP Q9GZ28 ALA 143 ENGINEERED MUTATION SEQRES 1 A 74 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER ALA SEQRES 2 A 74 SER PHE LEU LYS LYS THR MET PRO PHE LYS THR THR ILE SEQRES 3 A 74 GLU GLY THR VAL ASN GLY HIS TYR PHE LYS CYS THR GLY SEQRES 4 A 74 LYS GLY GLU GLY ASN PRO PHE GLU GLY THR GLN GLU MET SEQRES 5 A 74 LYS ILE GLU VAL ILE GLU GLY GLY PRO LEU PRO PHE ALA SEQRES 6 A 74 PHE HIS ILE LEU SER THR SER CYS NH2 SEQRES 1 C 168 CRK SER LYS THR PHE ILE LYS TYR VAL SER GLY ILE PRO SEQRES 2 C 168 ASP TYR PHE LYS GLN SER PHE PRO GLU GLY PHE THR TRP SEQRES 3 C 168 GLU ARG THR THR THR TYR GLU ASP GLY GLY PHE LEU THR SEQRES 4 C 168 ALA HIS GLN ASP THR SER LEU ASP GLY ASP CYS LEU VAL SEQRES 5 C 168 TYR LYS VAL LYS ILE LEU GLY ASN ASN PHE PRO ALA ASP SEQRES 6 C 168 GLY PRO VAL MET GLN ASN LYS ALA GLY ARG TRP GLU PRO SEQRES 7 C 168 GLY THR GLU ILE VAL TYR GLU VAL ASP GLY VAL LEU ARG SEQRES 8 C 168 GLY GLN SER LEU MET ALA LEU LYS CYS PRO GLY GLY ARG SEQRES 9 C 168 HIS LEU THR CYS HIS LEU HIS THR THR TYR ARG SER LYS SEQRES 10 C 168 LYS PRO ALA SER ALA LEU LYS MET PRO GLY PHE HIS PHE SEQRES 11 C 168 GLU ASP HIS ARG ILE GLU ILE MET GLU GLU VAL GLU LYS SEQRES 12 C 168 GLY LYS CYS TYR LYS GLN TYR GLU ALA ALA VAL GLY ARG SEQRES 13 C 168 TYR CYS ASP ALA ALA PRO SER LYS LEU GLY HIS ASN SEQRES 1 B 74 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER ALA SEQRES 2 B 74 SER PHE LEU LYS LYS THR MET PRO PHE LYS THR THR ILE SEQRES 3 B 74 GLU GLY THR VAL ASN GLY HIS TYR PHE LYS CYS THR GLY SEQRES 4 B 74 LYS GLY GLU GLY ASN PRO PHE GLU GLY THR GLN GLU MET SEQRES 5 B 74 LYS ILE GLU VAL ILE GLU GLY GLY PRO LEU PRO PHE ALA SEQRES 6 B 74 PHE HIS ILE LEU SER THR SER CYS NH2 SEQRES 1 D 168 CRK SER LYS THR PHE ILE LYS TYR VAL SER GLY ILE PRO SEQRES 2 D 168 ASP TYR PHE LYS GLN SER PHE PRO GLU GLY PHE THR TRP SEQRES 3 D 168 GLU ARG THR THR THR TYR GLU ASP GLY GLY PHE LEU THR SEQRES 4 D 168 ALA HIS GLN ASP THR SER LEU ASP GLY ASP CYS LEU VAL SEQRES 5 D 168 TYR LYS VAL LYS ILE LEU GLY ASN ASN PHE PRO ALA ASP SEQRES 6 D 168 GLY PRO VAL MET GLN ASN LYS ALA GLY ARG TRP GLU PRO SEQRES 7 D 168 GLY THR GLU ILE VAL TYR GLU VAL ASP GLY VAL LEU ARG SEQRES 8 D 168 GLY GLN SER LEU MET ALA LEU LYS CYS PRO GLY GLY ARG SEQRES 9 D 168 HIS LEU THR CYS HIS LEU HIS THR THR TYR ARG SER LYS SEQRES 10 D 168 LYS PRO ALA SER ALA LEU LYS MET PRO GLY PHE HIS PHE SEQRES 11 D 168 GLU ASP HIS ARG ILE GLU ILE MET GLU GLU VAL GLU LYS SEQRES 12 D 168 GLY LYS CYS TYR LYS GLN TYR GLU ALA ALA VAL GLY ARG SEQRES 13 D 168 TYR CYS ASP ALA ALA PRO SER LYS LEU GLY HIS ASN MODRES 1XMZ CRK C 65 MET CHROMOPHORE MODRES 1XMZ CRK C 65 TYR CHROMOPHORE MODRES 1XMZ CRK C 65 GLY CHROMOPHORE MODRES 1XMZ CRK D 65 MET CHROMOPHORE MODRES 1XMZ CRK D 65 TYR CHROMOPHORE MODRES 1XMZ CRK D 65 GLY CHROMOPHORE HET NH2 A 63 1 HET CRK C 65 23 HET NH2 B 63 1 HET CRK D 65 23 HET BME C 250 4 HET BME C 251 4 HET BME C 252 4 HET BME C 253 4 HET BME D 250 4 HET BME D 251 4 HET BME D 252 4 HETNAM NH2 AMINO GROUP HETNAM CRK 4-{(Z)-[2-[3-(METHYLSULFANYL)PROPANOYL]-5-OXO-1-(2- HETNAM 2 CRK OXOETHYL)-1,5-DIHYDRO-4H-IMIDAZOL-4- HETNAM 3 CRK YLIDENE]METHYL}BENZENOLATE HETNAM BME BETA-MERCAPTOETHANOL FORMUL 1 NH2 2(H2 N) FORMUL 2 CRK 2(C16 H15 N2 O4 S 1-) FORMUL 5 BME 7(C2 H6 O S) FORMUL 12 HOH *463(H2 O) HELIX 1 1 ALA A 54 CYS A 62 5 9 HELIX 2 2 PHE C 80 PHE C 84 5 5 HELIX 3 3 PRO C 183 LEU C 187 5 5 HELIX 4 4 SER B 1 LEU B 5 5 5 HELIX 5 5 ALA B 54 CYS B 62 5 9 HELIX 6 6 ASP D 78 SER D 83 1 6 HELIX 7 7 PRO D 183 LEU D 187 5 5 SHEET 1 A11 LYS C 71 TYR C 72 0 SHEET 2 A11 CYS C 210 ARG C 220 1 O GLY C 219 N LYS C 71 SHEET 3 A11 THR A 38 GLU A 47 -1 N ILE A 43 O TYR C 211 SHEET 4 A11 HIS A 22 ASN A 33 -1 N THR A 27 O GLU A 44 SHEET 5 A11 MET A 9 VAL A 19 -1 N MET A 9 O GLY A 32 SHEET 6 A11 CYS C 114 ASN C 124 1 O TYR C 117 N LYS A 12 SHEET 7 A11 PHE C 101 ASP C 111 -1 N THR C 103 O LEU C 122 SHEET 8 A11 PHE C 88 TYR C 96 -1 N PHE C 88 O THR C 108 SHEET 9 A11 HIS C 169 SER C 180 -1 O ARG C 179 N THR C 89 SHEET 10 A11 VAL C 153 LYS C 163 -1 N LEU C 162 O LEU C 170 SHEET 11 A11 ARG C 139 TRP C 140 -1 N ARG C 139 O LYS C 163 SHEET 1 B 6 LYS C 71 TYR C 72 0 SHEET 2 B 6 CYS C 210 ARG C 220 1 O GLY C 219 N LYS C 71 SHEET 3 B 6 HIS C 193 VAL C 205 -1 N PHE C 194 O ARG C 220 SHEET 4 B 6 GLY C 143 VAL C 150 -1 N GLU C 145 O GLU C 195 SHEET 5 B 6 VAL C 153 LYS C 163 -1 O ARG C 155 N TYR C 148 SHEET 6 B 6 ARG C 139 TRP C 140 -1 N ARG C 139 O LYS C 163 SHEET 1 C11 LYS D 71 TYR D 72 0 SHEET 2 C11 CYS D 210 ARG D 220 1 O GLY D 219 N LYS D 71 SHEET 3 C11 THR B 38 GLU B 47 -1 N ILE B 43 O TYR D 211 SHEET 4 C11 HIS B 22 ASN B 33 -1 N THR B 27 O GLU B 44 SHEET 5 C11 MET B 9 VAL B 19 -1 N PHE B 11 O GLY B 30 SHEET 6 C11 CYS D 114 ASN D 124 1 O TYR D 117 N LYS B 12 SHEET 7 C11 PHE D 101 ASP D 111 -1 N THR D 103 O LEU D 122 SHEET 8 C11 PHE D 88 TYR D 96 -1 N TRP D 90 O GLN D 106 SHEET 9 C11 HIS D 169 SER D 180 -1 O ARG D 179 N THR D 89 SHEET 10 C11 VAL D 153 LYS D 163 -1 N SER D 158 O LEU D 174 SHEET 11 C11 ARG D 139 TRP D 140 -1 N ARG D 139 O LYS D 163 SHEET 1 D 6 LYS D 71 TYR D 72 0 SHEET 2 D 6 CYS D 210 ARG D 220 1 O GLY D 219 N LYS D 71 SHEET 3 D 6 HIS D 193 GLU D 203 -1 N PHE D 194 O ARG D 220 SHEET 4 D 6 GLY D 143 VAL D 150 -1 N GLU D 145 O GLU D 195 SHEET 5 D 6 VAL D 153 LYS D 163 -1 O ARG D 155 N TYR D 148 SHEET 6 D 6 ARG D 139 TRP D 140 -1 N ARG D 139 O LYS D 163 LINK C CYS A 62 N NH2 A 63 1555 1555 1.39 LINK C3 CRK C 65 N SER C 66 1555 1555 1.30 LINK SG CYS C 114 S2 BME C 251 1555 1555 2.03 LINK SG CYS C 164 S2 BME C 252 1555 1555 2.04 LINK SG CYS C 210 S2 BME C 253 1555 1555 2.03 LINK SG CYS C 222 S2 BME C 250 1555 1555 2.05 LINK C CYS B 62 N NH2 B 63 1555 1555 1.38 LINK C3 CRK D 65 N SER D 66 1555 1555 1.33 LINK SG CYS D 114 S2 BME D 251 1555 1555 2.00 LINK SG CYS D 164 S2 BME D 252 1555 1555 1.93 LINK SG CYS D 222 S2 BME D 250 1555 1555 2.03 CISPEP 1 GLY A 49 PRO A 50 0 -2.18 CISPEP 2 PHE C 84 PRO C 85 0 5.27 CISPEP 3 GLY B 49 PRO B 50 0 -2.19 CISPEP 4 PHE D 84 PRO D 85 0 11.14 SITE 1 AC1 3 SER A 61 CYS A 62 CRK C 65 SITE 1 AC2 6 GLY C 143 THR C 144 PHE C 194 ASP C 196 SITE 2 AC2 6 ARG C 220 CYS C 222 SITE 1 AC3 3 PRO A 10 PHE A 11 CYS C 114 SITE 1 AC4 5 PRO C 131 CYS C 164 ARG C 168 HOH C 407 SITE 2 AC4 5 HOH C 469 SITE 1 AC5 4 LYS A 42 ILE A 43 GLU A 44 CYS C 210 SITE 1 AC6 3 SER B 61 CYS B 62 CRK D 65 SITE 1 AC7 6 GLY D 143 THR D 144 PHE D 194 ASP D 196 SITE 2 AC7 6 ARG D 220 CYS D 222 SITE 1 AC8 3 PRO B 10 PHE B 11 CYS D 114 SITE 1 AC9 6 LEU D 162 CYS D 164 ARG D 168 LEU D 170 SITE 2 AC9 6 HOH D 399 HOH D 414 CRYST1 76.520 125.400 92.750 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013068 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007974 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010782 0.00000 MTRIX1 1 0.188266 0.002404 -0.982115 99.38400 1 MTRIX2 1 0.004802 -0.999987 -0.001527 67.75500 1 MTRIX3 1 -0.982106 -0.004428 -0.188275 120.49300 1